Zdrowie i gospodarka · 27/07/2022
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products; Guidance for Industry; Availability
The US Food and Drug Administration (FDA) has released a final guidance document titled 'General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products' to help pharmaceutical companies conduct clinical trials in newborn populations, finalizing a draft released on August 1, 2019.